BioAlliance, SpePharm sales and marketing update

BioAlliance launched Loramyc miconazole to treat oropharyngeal candidiasis in immunocompromised patients in the U.K., Germany and Denmark. The extended-release, bioadhesive antifungal buccal tablet w...